News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hansard Adam
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Sold 4,495 shares
@ $0.91, valued at
$4.1k
Granted 300,000 shares
@ $0 |
|
| 08/04/2022 |
4
| Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Disposed/sold 50,000 options to buy
@ $2.02, valued at
$101k
Disposed/sold 50,000 options to buy
@ $1.05, valued at
$52.5k
Disposed/sold 21,100 options to buy
@ $4.17, valued at
$88k
Disposed/sold 21,100 options to buy
@ $1.05, valued at
$22.2k
Disposed/sold 21,100 options to buy
@ $9.44, valued at
$199.2k
Disposed/sold 32,339 options to buy
@ $23.15, valued at
$748.6k
Disposed/sold 32,339 options to buy
@ $1.05, valued at
$34k
Disposed/sold 104,665 options to buy
@ $34.28, valued at
$3.6M
Disposed/sold 104,665 options to buy
@ $1.05, valued at
$109.9k
|
|
| 04/15/2022 |
4
| Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.02, valued at
$101k
|
|
| 01/11/2022 |
4
| Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 31,700 shares
@ $0
Granted 21,100 options to buy
@ $4.17, valued at
$88k
|
|
| 01/11/2022 |
4/A
| Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 31,700 shares
@ $0 |
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Sold 2,894 shares
@ $18.35, valued at
$53.1k
|
|
| 12/14/2020 |
4
| Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 81,700 options to buy
@ $23.15, valued at
$1.9M
|
|
| 03/11/2020 |
4
| Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 36,464 shares
@ $0
Granted 179,425 options to buy
@ $34.28, valued at
$6.2M
|
|
| 03/05/2020 |
3
| Hansard Adam (Chief Commercial Officer) has filed a Form 3 on Applied Therapeutics Inc. |
|
|